Search results
Found 25941 matches for
Work by researchers at MRC HIU zeroes in on the mechanisms by which T cells respond to Salmonella infections.
Dr Ashwin Jainarayanan selected for 2024 Schmidt Science Fellow program
1 May 2024
Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow – an honour bestowed on only 32 exceptional early career researchers worldwide. The 2024 Fellows, nominated by 26 of the world’s leading institutions across North America, Europe, and Asia, were chosen for their potential to drive sector-wide change by pursuing ambitious interdisciplinary science projects.
New study to improve vaccines and therapeutics development
NDM
1 May 2024
A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it.
Unveiling of Medawar Nobel Prize medal
29 April 2024
On Thursday 25th April 2024, the Oxford immunology community celebrated the kind donation of Sir Peter Medawar’s Nobel Prize medal to the University.
Immunology at the MRC WIMM
WIMM
29 April 2024
For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit speak about their research.
The potential of the R21/Matrix vaccine to redefine malaria prevention
25 April 2024
Researchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.
New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection
17 April 2024
A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.
Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine
16 April 2024
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.
Aerosol human infection model gives hope for TB vaccine development
16 April 2024
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.
New study reveals how T cells gain and maintain tolerance to gut bacteria
3 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
Novel pairing of proteins controls tumour growth
3 April 2024
New research by the CAMS Oxford Institute, the MRC Translational Immune Discovery Unit and the Kennedy Institute researchers describes a novel pairing of integrins which could improve T cell control of cancer.
Thanks for the Memories Immunology Workshop at the Science and Industry Museum, Manchester
28 March 2024
The Thanks for the Memories public engagement programme – bringing together the worlds of immunology research and music composition for secondary school students in Manchester and Oxford – had a fantastic day with Manchester Co-op Academy students at the Science and Industry Museum in Manchester on Friday 8th March.
Developing the world's first lung cancer vaccine
26 March 2024
Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.
PD-1 gets an “A” for team-work
8 March 2024
A new understanding of the PD-1 axis (programmed death cell) could help shape ongoing efforts to improve treatments for cancer and autoimmune diseases.
Ricardo Fernandes awarded a Cancer Research UK Immunology Project Award
8 March 2024
CAMS-Oxford Institute Principal Investigator, Ricardo Fernandes, has been awarded a competitive grant from Cancer Research UK to study anti-tumour T cell responses.
New study suggests antiviral treatment course is not long enough to treat COVID-19 in at risk patients
26 February 2024
New research published in Nature Communications suggests that the currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19.
Study finds high number of persistent COVID-19 infections in the general population
BDI
22 February 2024
A new study led by the Big Data Institute at NDM has found persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer.
Rising antimicrobial resistance in enteric fever across 75 countries
16 February 2024
Recent findings by the Global Research on Antimicrobial Resistance Project at NDM's Centre for Tropical Medicine and Global Health revealed the resistance patterns for a priority pathogen--also known as typhoid fever--with high mortality and morbidity in resource-constrained settings.
New study provides framework for optimising the design of antibody therapeutics
WIMM
13 February 2024
R21 malaria vaccine phase III trial confirms high efficacy and safety
Jenner
5 February 2024
The phase III trial data results of the R21/Matrix-M vaccine, developed by the Jenner Institute and the Serum Institute of India have confirmed high efficacy and supported regulatory approvals and licensure in several African countries.
World Cancer Day 2024: Highlighting cancer research at the MRC WIMM
WIMM
4 February 2024
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.